From Nasdaq:

Momentum investing is the approach of following a stock’s recent trend, whether upwards or downwards, with the goal of taking advantage of the trend and making profitable trades. It revolves around the idea of buying high and selling higher, and successful momentum investing can lead to timely and profitable trades.

Using the Zacks Momentum Style Score, we look at Amphastar Pharmaceuticals (AMPH), with a current Momentum Style Score of A. AMPH also has a Zacks Rank of #1 (Strong Buy), and stocks with a Zacks Rank of #1 or #2, along with Style Scores of A or B, tend to outperform the market over the next one-month period.

A critical benchmark for AMPH’s momentum is its price activity. Over the past week, shares have risen 1.53%, and they have experienced a 6.79% monthly price change. This compares favorably to the industry’s performance, with a 5.86% monthly change.

The Zacks Momentum Style Score also factors in earnings estimate revisions. In the last 60 days, AMPH’s consensus estimate rose from $2.72 to $3.21 for the full year. For the next fiscal year, 2 estimates moved upwards, and none lowered.

AMPH is a #1 (Strong Buy) stock with a Momentum Score of A, and its favorable momentum aspects make it a promising pick for investors seeking short-term gains.

Zacks experts name their best stock pick to potentially double, a little-known chemical company with significant potential for share repurchase and consistent earnings estimates and soaring demand. To see the full article and recommendations from Zacks Investment Research, click the following links in the article.



Read more: Amphastar Pharmaceuticals (AMPH) Is Up 1.53% in One Week: What You Should Know